GlassScriptPhysician profile
Jeffrey S Barton
NPI 1053380360
$970.72
in general payments reported to CMS, 2019-2025
17 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.54 · 2021: $17.91 · 2022: $65.08 · 2023: $125 · 2024: $514 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $828 · Travel and Lodging: $38.00 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.45 |
| Travel and Lodging | $38.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $511.97 | 2024-2025 | |
| Novo Nordisk INC | $137.31 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Olympus Corporation of The Americas | $49.11 | 2025 | Itind System |
| Dexcom, INC. | $37.32 | 2023-2025 | Dexcom G6 Transmitter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $33.03 | 2025 | Caplyta |
| Exact Sciences Corporation | $31.07 | 2023-2024 | Cologuard Collection Kit |
| Smith+Nephew, INC. | $27.07 | 2025 | Renasys Go V2 Home |
| Biohaven Pharmaceutical Holding Company LTD. | $23.25 | 2022 | |
| Merck Sharp & Dohme LLC | $19.81 | 2024 | Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $16.85 | 2023 | |
| Glaxosmithkline, LLC. | $15.59 | 2025 | Trelegy Ellipta |
| Baxter Healthcare | $13.10 | 2023 | Floseal |
| Abbvie INC. | $13.02 | 2023 | Dalvance |
| Hologic Sales and Service, LLC | $12.54 | 2019 | |
| Dynavax Technologies Corporation | $11.68 | 2023 | Heplisav-B |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medela LLC | $9.16 | 2023 | Invia Motion Endure |
| Phathom Pharmaceuticals, INC. | $8.84 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.